FOXO Technologies Inc., a company incorporated in Delaware and operating in the health care sector, has filed a Form D notice with the United States Securities and Exchange Commission (SEC) for an exempt offering of securities. The filing, dated October 23, 2024, indicates that the offering is not being made in connection with a business combination transaction. The principal place of business for FOXO Technologies is listed as Minneapolis, Minnesota. The notice includes information about related persons, including Mark White, the Interim Chief Executive Officer, and Martin Ward, the Interim Chief Financial Officer, among others. The company has claimed federal exemptions under Rule 506(b) and Securities Act Section 4(a)(5), and has reported the sale of debt securities totaling $121,900 USD, with the date...Show More

FOXO Technologies Inc., a company incorporated in Delaware and operating in the health care sector, has filed a Form D notice with the United States Securities and Exchange Commission (SEC) for an exempt offering of securities. The filing, dated October 23, 2024, indicates that the offering is not being made in connection with a business combination transaction. The principal place of business for FOXO Technologies is listed as Minneapolis, Minnesota. The notice includes information about related persons, including Mark White, the Interim Chief Executive Officer, and Martin Ward, the Interim Chief Financial Officer, among others. The company has claimed federal exemptions under Rule 506(b) and Securities Act Section 4(a)(5), and has reported the sale of debt securities totaling $121,900 USD, with the date of first sale on October 7, 2024. The offering is not intended to last more than one year, and the minimum investment accepted from any outside investor was $121,900 USD. No sales commissions or finder's fees were reported, and the proceeds from the offering are not being used for payments to any executive officers, directors, or promoters.